1. X
  2. Pfizer Inc.
Log inSign up
Pfizer Inc.
11.4K posts
Pfizer Inc. profile banner
@pfizer

Pfizer Inc.

@pfizer
We’re celebrating over 175 years of daring scientific innovation and we’re not done yet. Protect your health at PfizerForAll.com on.pfizer.com/CGs
New York, NY
pfizer.com
Joined July 2009
2,100
Following
469.4K
Followers
RepliesRepliesRepostsRepostsMediaMedia

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
  • @pfizer
    Pfizer Inc.
    @pfizer
    Aug 28
    As #ESCCongress 2026 returns to Munich, early diagnosis and treatment initiation remain the biggest opportunity to improve outcomes in ATTR-CM, an underdiagnosed cause of heart failure. Explore how the landscape has evolved and what needs to happen next: bit.ly/3UIiVV0
    Image
    00:00
  • @pfizer
    Pfizer Inc.
    @pfizer
    Aug 27
    250 years of American innovation have shown what’s possible when different minds and ideas come together. As we look to what’s next, Pfizer is proud to build on that spirit of innovation, continuing to advance science and explore what’s possible for the future of medicine.
    Image
    00:00
  • @pfizer
    Pfizer Inc.
    @pfizer
    Aug 25
    Every dose of medicine you take is the final step in a long journey—one that runs through qualified suppliers, rigorous testing, and continuous monitoring. Pfizer's Bina Nair and Kenya Edmondson walk through what it takes to make sure every dose performs the same way,
    Image
  • @pfizer
    Pfizer Inc.
    @pfizer
    Aug 18
    For more than a century, scientists studied cancer as a caricature of healthy tissue. Spatial transcriptomics is changing that. Now, with the ability to map tumors cell by cell, researchers are rethinking what’s possible in cancer treatment. Read more: on.pfizer.com/4crXIVm
    Image
  • @pfizer
    Pfizer Inc.
    @pfizer
    Aug 13
    Our global survey found unspoken compromises may persist in hemophilia care, pointing to a need for more open conversations. With 6 in 10 patients saying HCPs are their primary source of information on newer treatments, shared-decision making can help evolve care. See more:
    Image
    00:00
Advertisement
Advertisement